On the BSE index, Tata Steel, Vendata, ONGC, NTPC, Yes Bank, Infosys, SBI and Sun Pharma were among the major gainers with their stocks rising as much as 4.78%. Of the 30 Sensex constituents, 25 closed.. IndiaTimes - Published
Top gainers in the Sensex pack include ONGC, Vedanta, Yes Bank, Bajaj Finance, Axis Bank, Sun Pharma, L&T, Tata Steel, HDFC, Reliance and Bharti Airtel, rising up to 2.12 per cent. On the other hand,.. IndiaTimes - Published
On the BSE index, Tata Consultancy Services, Yes Bank, Reliance Industries, ITC, Sun Pharma, Coal India and Asian Paints were among the worst performers with their stocks down as much as 3.02 per cent... IndiaTimes - Published
Nifty 50 has strong multi-month support at 10580-10600 levels, which is the last month low. Below these levels, we expect a sharp profit booking across sectors and stocks DNA - Published
The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal hit by one-time deferred tax adjustment. Zee News - Published Also reported by •Firstpost
Sun Pharmaceutical Industries has registered gross sales of Rs 7,657 crore in the quarter ending December 2018, marking 16 per cent growth over the same quarter of previous Sify - Published
Drug major Sun Pharmaceutical Industries Tuesday reported a nearly four-fold jump in its consolidated net profit at Rs 1,241.85 crore for the quarter ended 31 December, 2018 Firstpost - Published
India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market. Reuters India - Published
Sun Pharmaceutical Industries Ltd, India's largest drugmaker by market value, posted a nearly four-fold jump in quarterly profit on Tuesday, beating estimates. Reuters India - Published
Sensex was trading 161.53 points, or 0.44 percent, higher at 37,136.76. NSE Nifty rose 33.05 points, or 0.30 percent to 11,095.50. Firstpost - Published
Meanwhile, Tata Motors, Sun Pharma, Coal India and Bajaj Auto were the top losers that capped the gains, falling up to 2.27 percent. Zee News - Published
Shanghvi Finance, which is a major shareholder in Sun Pharma, pledged a portion of its stake in India's largest drugmaker to facilitate Suraksha Realty for raising Rs 100 crore through commercial.. Firstpost - Published
India's top drugmaker by market value Sun Pharmaceutical Industries announced on Tuesday a new local distributor and other measures in a bid to ease investor concerns over its corporate governance,.. Reuters India - Published
Shares of Sun Pharmaceuticals on Tuesday surged over 6 percent after it replaced its domestic formulations distributor Aditya Medisales with its own subsidiary in the backdrop of a second whistleblower.. Firstpost - Published
Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday it will make its unit the new distributor for its domestic formulations business, replacing Aditya Medisales Ltd. Reuters India - Published
Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday it will make its unit the new distributor for its domestic formulations business, replacing Aditya Medisales. Reuters India - Published
After a heavy sell-off by the end of last week, stocks of Sun Pharma closed nearly 2 per cent higher on Monday after the company claimed the reports against it of unfair business practices were.. Sify - Published
Shares of Sun Pharmaceutical Industries surged 2 percent on Monday as it sought SEBI's intervention in the issue of alleged unfair business practices against the company Firstpost - Published
Reliance Industries, Sun Pharma, Infosys, Bajaj Finance, HDFC Bank and Bharti Airtel were among the top trading stocks on the BSE platform with their stocks rising as much as 2,75 per cent. On NSE,.. IndiaTimes - Published
Pharmaceutical major Sun Pharma's stock gained 4 per cent to touch a high of Rs 406.35 on Monday after it ended Friday's trade lower at more than 8 per cent. Sify - Published
The stock of pharmaceutical major Sun Pharma ended up as the top loser on the BSE Sensex on Friday following reports of a complaint by a whistleblower to the Securities and Exchange Board of India.. Sify - Published Also reported by •Reuters India
Heavy sell-off in the healthcare stocks led by Sun Pharmaceuticals kept the key equity indices subdued for most part of the Friday's trading session, before positive global markets helped them recover.. Sify - Published
Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's.. Reuters India - Published
In November 2018, a whistleblower approached Sebi with a document alleging various irregularities by the company, its promoter and others. Zee News - Published
The scrip after a weak opening further tumbled 12.11 percent to hit a multi-year low of Rs 375.40 on BSE. Firstpost - Published Also reported by •Reuters India
Other gainers included Kotak Bank, HCL Tech, ONGC, Asian Paints, Vedanta, HDFC Bank, Bajaj Finance, Maruti and TCS, gaining up to 1.41 percent. Zee News - Published
Indian shares fell on Friday, dragged by Sun Pharmaceutical Industries Ltd after reports of fresh allegations by a whistleblower, though gains in Reliance Industries Ltd after strong quarterly earnings.. Reuters India - Published
The Sensex settled 52.79 points or 0.15 percent higher at 36,374.08; and the broader NSE Nifty inched up 14.90 points or 0.14 percent to 10,905.20 Firstpost - Published
Shares of India's Sun Pharmaceutical Industries Ltd slumped over 13 percent on Friday to near six-year low, after a media report of a complaint by a whistleblower raised fresh concerns on the.. Reuters India - Published
Sun Pharmaceutical has said its US subsidiary has started voluntarily recalling 13,918 cartons of Vecuronium Bromide Injection of 10 mg and 20 mg strengths from US market at the hospital level,.. Firstpost - Published
The acquisition of 100 percent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing. Firstpost - Published
The acquisition of 100 per cent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing. Zee News - Published
On BSE, Tata Steel, Vedanta, Sun Pharma, Tata Motors, IndusInd Bank and Kotak Mahindra Bank were among the top gainers with their stocks surging as much as 1.59 per cent. On the NSE platform, apart.. IndiaTimes - Published
On the BSE index, Sun Pharma, Bajaj Finance, Vedanta, HDFC, Yes Bank and ICICI Bank were the top gainers, rising as much as 2.98 per cent. On NSE, all the sub-indices ended in green with Nifty Media.. IndiaTimes - Published
Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and.. Firstpost - Published
On the BSE platform, Sun Pharma, Infosys, ICICI Bank and State Bank of India (SBI) were among the major gainers with their stocks surging as much as 1.39 per cent. On NSE, sub-indices Nifty Pharma and.. IndiaTimes - Published
Sun Pharma, PowerGrid, Mahindra and Mahindra, Vedanta, Asian Paints and L&T were among the major gainers on the BSE platform with their stocks rising as much as 2.98 per cent. On NSE, sub-indices Nifty.. IndiaTimes - Published
In August 2017, Sun Pharmaceutical, Shanghvi and nine other entities settled an insider trading probe on payment of Rs 18 lakh towards settlement charges Firstpost - Published
Did Empire Actor Jussie Smollett Fake His Own Attack?
Brexit: Who Is the Independent Group?
Bernie Sanders Launches 2020 Presidential Bid
The Next James Bond Movie Gets Pushed Back – Again
Twitter Retains Private Messages Even After They’re Deleted – Report
Why Are Indian Lawmakers Pushing for ‘Tiktok’ to Be Banned?
Trump Declares State of Emergency - And Could Be Getting Sued as a Result
Opportunity Bows Out - NASA Says Goodbye to Mars Rover
Send us your feedback | LIKE us on Facebook FOLLOW us on Twitter • FOLLOW us on Pinterest